Bayer AG (BAYNd)
FRA • Healthcare
July 10, 2026 at 15:30 UTC
About Bayer AG
Bayer AG trades on XETRA as BAYN.DE and operates across branded medicines, consumer health products, and agricultural inputs, placing it in healthcare and the broad Drug Manufacturers - General group. Its business spans pharmaceuticals, self-care, and crop science, and it generated EUR 45.6 billion of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Bayer AG's Technical Indicators Summary
BAYNd shows a bullish technical posture driven by strong trend confirmation and constructive momentum while short-term pace remains mixed. The ADX is elevated, signaling a robust directional move, and momentum indicators including MACD and Momentum are positive, supporting the buy bias. Price sits well above major longer-term averages, with the 200-day averages comfortably below current levels, while short-term averages are mixed but leaning supportive. Volume-based OBV is positive and volatility is moderate, so intraday swings are contained. Technical takeaway: Strong Buy.
| Indicator | Value |
|---|---|
RSI (14) | 67.73 |
Stochastic %K (14, 3, 3) | 77.48 |
CCI (20) | 68.17 |
WPR (14) | -23.41 |
Momentum (10) | 3.12 |
MFI | 73.87 |
MACD Level (12, 26) | 3.60 |
Bollinger Bands | $32.19 - $57.61 |
ATR (14) | $1.91 (3.82%) |
ADX (14) | 44.90 |
OBV | 67,346,803 |
VWAP | $50.41 |
Classic Pivot Point | $50.71 |
Fibonacci Pivot Point | $50.71 |
Exponential Moving Averages | $36.70 - $49.21(5 indicators) |
Simple Moving Averages | $37.23 - $50.26(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
By the close, BAYNd continued to sit slightly below yesterday’s 50.70, with a small -0.87% gap down. End-of-day sector performance was slightly negative (-0.66%), mildly offsetting stock-specific strength. BAYNd watchers focus on Bayer's €3bn Apollo contraceptives division deal as a key driver.
Trading Volume
Below avg (4.0M)
2M
vs S&P 500 Today
Underperforming Market
-0.91%
52-Week Position
Upper range
87.4%
Updated: July 10, 2026 at 15:02 UTC
Quote Summary
BAYNd Headlines
Supreme Court Ruling Lifts Bayer Shares
June 25, 2026
Biotech, Pharma Stocks Draw Fresh Valuation Focus
April 2, 2026
Moderna, Mexico sign mRNA vaccine pact
February 11, 2026